USPTO Examiner BRUTUS JOEL F - Art Unit 3797

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18975086INTRAVASCULAR IMAGING CATHETERDecember 2024February 2026Allow1510NoNo
18974220BIMODAL METHOD FOR DETECTION AND MEASUREMENT OF MACULAR PIGMENTS IN RETINA TISSUEDecember 2024November 2025Allow1120NoNo
18962176MAGNETIC TOLERANT IMAGINGNovember 2024March 2026Allow1510NoNo
18923852MRI Compatible Interventional WireguideOctober 2024March 2026Allow1710NoNo
18882672Signal Processing Methods and Systems for Biomagnetic Field ImagingSeptember 2024February 2026Allow1710NoNo
18812581NEUROMODULATION TECHNIQUESAugust 2024February 2026Allow1810NoNo
18809058SYSTEMS, DEVICES, AND METHODS OF TREATING TISSUE AND CELLULITE BY NON-INVASIVE ACOUSTIC SUBCISIONAugust 2024March 2026Abandon1810NoNo
18796498MEDICAL SYSTEMS AND RELATED METHODSAugust 2024January 2026Allow1710NoNo
18777481HYBRID ELECTROMAGNETIC DEVICE FOR REMOTE CONTROL OF MICRO-NANO SCALE ROBOTS, MEDICAL TOOLS AND IMPLANTABLE DEVICESJuly 2024March 2026Abandon2010NoNo
18762863SENSORS FOR CATHETER PUMPSJuly 2024February 2026Allow2010NoNo
18726442MEDICAL IMAGE ACQUISITION UNIT ASSISTANCE APPARATUSJuly 2024January 2026Allow1910NoNo
18752394BIOMETRIC APPARATUS, BIOMETRIC METHOD, AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUMJune 2024January 2026Abandon1930YesNo
18660170SYSTEM AND METHOD FOR LOCAL THREE DIMENSIONAL VOLUME RECONSTRUCTION USING A STANDARD FLUOROSCOPEMay 2024February 2026Allow2130NoNo
18658540IMAGE PROCESSING APPARATUS, MEDICAL IMAGE DIAGNOSTIC APPARATUS, AND BLOOD PRESSURE MONITORMay 2024November 2025Allow1820NoNo
18608794HYBRID REGISTRATION METHODMarch 2024October 2025Allow1910NoNo
18603191Artificial Intelligence System for Comprehensive Medical Diagnosis, Prognosis, and Treatment Optimization through Medical ImagingMarch 2024March 2026Allow2410NoNo
18400832INTRAOPERATIVE VIDEO REVIEWDecember 2023October 2025Allow2130NoNo
18524898SYSTEM AND METHOD FOR NAVIGATIONNovember 2023December 2025Allow2520NoNo
18512580MAP DEFORMATION FOR ANATOMICAL MAPPINGNovember 2023October 2025Allow2310NoNo
18278167Self-Learning and Non-Invasive Bladder Monitoring Systems and MethodsAugust 2023October 2025Allow2610NoNo
18276989CALIBRATION CRADLE FOR THREE-DIMENSIONAL SCANNERAugust 2023February 2026Allow3010NoNo
18274478MRI SYSTEM, IN PARTICULAR A METHOD AND SYSTEM FOR GENERATING A CARDIAC TRIGGER SIGNALJuly 2023June 2025Allow2310NoNo
18336807METHOD AND APPARATUS FOR PERFORMING SINGLE GATING IN POSITRON EMISSION TOMOGRAPY SYTEMSJune 2023February 2026Allow3210NoNo
18114320Technique for Determining a Marker Arrangement That Defines Marker Positions of a TrackerFebruary 2023October 2025Allow3210NoNo
17927054METHOD AND APPARATUS FOR MULTIMODAL SOFT TISSUE DIAGNOSTICSNovember 2022December 2025Allow3611NoNo
17957345TECHNIQUES FOR HEART RATE DETECTIONSeptember 2022February 2026Allow4030YesNo
17904679PREDICTING SUCCESSFUL GENERATION AND INHIBITION OF SEIZURE-LIKE AFTERDISCHARGES AND MAPPING THEIR SEIZURE NETWORKS USING FMRIAugust 2022October 2025Allow3810NoNo
17746041WIRELESS GATING SYSTEM FOR MAGNETIC RESONANCE IMAGINGMay 2022December 2025Allow4311NoNo
17711023DEVICE AND METHOD FOR ASSISTING LAPAROSCOPIC SURGERY - DIRECTING AND MANEUVERING ARTICULATING TOOLMarch 2022March 2026Abandon4740NoNo
17503253DETERMINATION OF WHITE-MATTER NEURODEGENERATIVE DISEASE BIOMARKERSOctober 2021November 2025Allow4910NoNo
17368756AUTOMATIC TRACKING OF TARGET TREATMENT SITES WITHIN PATIENT ANATOMYJuly 2021November 2025Allow5240NoNo
16050318FORMULATION OF SOLID NANO-SIZED PARTICLES IN A GEL-FORMING SYSTEMJuly 2018June 2019Allow1020NoNo
15295389AUTOMATIC EXTRACTION OF DISEASE-SPECIFIC FEATURES FROM DOPPLER IMAGESOctober 2016February 2019Allow2810NoNo
15158503MEDICAL DEVICE GUIDEWIRE WITH HELICAL CUTOUT AND COATINGMay 2016December 2018Allow3140NoYes
14481414ULTRASONIC DIAGNOSTIC APPARATUS, IMAGE PROCESSING APPARATUS, AND IMAGE PROCESSING METHODSeptember 2014September 2018Allow4830NoNo
14301540PORTABLE ULTRASONIC PROBE HAVING A FOLDER PARTJune 2014February 2019Allow5630NoNo
11915625VELOCITY MEASURING METHOD AND VELOCITY MEASURING DEVICE USING THE SAMEMarch 2009January 2011Allow3720YesNo
12114888T1-CORRECTED PROTON RESONANCE FREQUENCY SHIFT THERMOMETRYMay 2008June 2011Allow3810NoNo
11970707APPARATUS AND METHOD FOR ALIGNING A LIGHT POINTER WITH A MEDICAL INTERVENTIONAL DEVICE TRAJECTORYJanuary 2008May 2012Allow5230NoYes
11904413MEDICAL SYSTEM COMPRISING A DETECTION DEVICE FOR DETECTING AN OBJECT AND COMPRISING A STORAGE DEVICE AND METHOD THEREOFSeptember 2007July 2012Allow5750NoNo
11179044METHOD AND APPARATUS FOR SURGICAL NAVIGATIONJuly 2005March 2012Allow6060YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BRUTUS, JOEL F.

Strategic Value of Filing an Appeal

Total Appeal Filings
2
Allowed After Appeal Filing
1
(50.0%)
Not Allowed After Appeal Filing
1
(50.0%)
Filing Benefit Percentile
84.3%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner BRUTUS, JOEL F - Prosecution Strategy Guide

Executive Summary

Examiner BRUTUS, JOEL F works in Art Unit 3797 and has examined 12 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 49 months.

Allowance Patterns

Examiner BRUTUS, JOEL F's allowance rate of 100.0% places them in the 100% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BRUTUS, JOEL F receive 2.92 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BRUTUS, JOEL F is 49 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +0.0% benefit to allowance rate for applications examined by BRUTUS, JOEL F. This interview benefit is in the 17% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 28.6% of applications are subsequently allowed. This success rate is in the 52% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 44.4% of cases where such amendments are filed. This entry rate is in the 68% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 8.3% of allowed cases (in the 91% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.